A Koerner, J Kratzsch, W Kiess - Best Practice & Research Clinical Endocrinology & …, 2005 - Elsevier With the growing prevalence of obesity, scientific interest in the biology of
adipose tissue has been extended to the secretory products of adipocytes, since
they are increasingly shown to affect several aspects in the pathogenesis ... Cited by 133 - Related articles - All 12 versions
- ►onlinejacc.org SH Han, MJ Quon, J Kim, KK Koh - Journal of the American College of Cardiology, 2007 - Elsevier Adiponectin is a protein secreted specifically by adipose cells that may couple
regulation of insulin sensitivity with energy metabolism and serve to link
obesity with insulin resistance. Obesity-related disorders including the ... Cited by 90 - Related articles - BL Direct - All 20 versions
- ►diabetesjournals.org C Menzaghi, V Trischitta, A Doria - Diabetes, 2007 - Am Diabetes Assoc Recent evidence points to molecules secreted by the adipose tissue, or
adipokines, as possible links between increased adipose mass and metabolic
abnormalities. Among these molecules, adiponectin has drawn much attention ... Cited by 52 - Related articles - BL Direct - All 9 versions
- ►darkmay.cz [PDF] DR Gable, SJ Hurel, SE Humphries - Atherosclerosis, 2006 - Elsevier The increasing prevalence of obesity and metabolic syndrome/insulin resistance
has attracted considerable interest due to their identification as risk factors
for cardiovascular disease and, hence, targets for cardiovascular disease ... Cited by 39 - Related articles - All 15 versions
JH Shon, YR Yoon, WS Hong, PM Nguyen, SS … - PHARMACOKINETICS AND DRUG DISPOSITION, 2005 - journals2005.pasteur.ac.ir Effect of itraconazole on the pharmacokinetics and pharmacodynamics of
fexofenadine in relation to the MDR1 genetic polymorphism Objective: Our
objective was to evaluate the effect of itraconazole, a P-glycoprotein ... Cited by 34 - Related articles - All 6 versions
ES Kang, SY Park, HJ Kim, CS Kim, CW Ahn, … - Clinical pharmacology and therapeutics, 2005 - 134.68.189.85 Objective: The aim of this study was to examine the effects of the Pro12Ala
polymorphism of the peroxisome proliferator–activated receptor (PPAR) 2 gene
on the response to rosiglitazone in patients with type 2 diabetes mellitus. ... Cited by 32 - Related articles - View as HTML - All 8 versions
WS Yang, LM Chuang - Journal of molecular medicine, 2006 - Springer Abstract Adiponectin, an adipose-derived plasma protein, has been well
established to be an important biomarker for metabolic syndrome and its
complications after exhausted studies in humans. Animal and cell culture ... Cited by 33 - Related articles - BL Direct - All 4 versions
JK Wolford, KA Yeatts, SK Dhanjal, MH … - Diabetes, 2005 - Am Diabetes Assoc Thiazolidinediones (TZDs) are peroxisome proliferator–activated receptor-γ
(PPARG) agonists used to treat type 2 diabetes. TZDs can also be used to reduce
rates of type 2 diabetes in at-risk individuals. However, a large fraction ... Cited by 31 - Related articles - BL Direct - All 5 versions
HJ Kim, ES Kang, DJ Kim, SH Kim, CW Ahn, … - CLINICAL ENDOCRINOLOGY-OXFORD-, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 33 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org ES Kang, BS Cha, HJ Kim, HJ Kim, SH Kim, … - Diabetes care, 2006 - Am Diabetes Assoc RESULTS—Although fasting plasma glucose and HbA 1c levels decreased; mean body
weight increased significantly after rosiglitazone treatment. Among the four
SNPs tested, only the PLIN 11482G>A polymorphism was associated with weight ... Cited by 22 - Related articles - BL Direct - All 7 versions
